Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH

NCT02631421 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT02631421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02631421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH
Lead sponsor
Vanderbilt University
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
June 30, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension